8-12-13 4:00 PM EDT | Email Article

Revenues, operating profit, EBITDA and net profit all up substantially over same period last year; Net income of $0.09/share contributes to trailing twelve months of net income of $0.15/share; Increases 2013 guidance

ANN ARBOR, Mich., Aug. 12, 2013 /PRNewswire/ -- Arotech Corporation (NasdaqGM: ARTX), a provider of quality defense and security products for the military, law enforcement and security markets, today reported results for the quarter and six months ended June 30, 2013.

Second Quarter Results

Revenues for the second quarter reached $22.4 million, compared to $20.4 million for the corresponding period in 2012, an increase of 9.9%.

Gross profit for the quarter was $6.3 million, or 28.2% of revenues, compared to $3.4 million, or 16.5% of revenues, for the corresponding period last year, an 11.7 point improvement in the gross margin percentage.

Adjusted Earnings (Loss) Before Interest, Taxes, Depreciation and Amortization (adjusted EBITDA) for the quarter was $2.5 million, compared to $(0.1) million for the corresponding    period in 2012. Arotech believes that information concerning adjusted EBITDA enhances overall understanding of its current financial performance. Arotech computes adjusted EBITDA, which is a non-GAAP financial measure, as reflected in the table below.

The Company reported an operating profit for the first quarter of 2013 of $1.6 million, compared to an operating loss of $(0.7) million for the corresponding period in 2012.

The Company's net income from continuing operations for the second quarter was $1.5 million, or $0.09 per diluted share, compared to a net loss of $(1.3) million, or $(0.09) per share, for the corresponding period last year.

"We are proud to report a record quarter for Arotech with  solid profitability, and I note that Arotech now has a trailing twelve-month profit of approximately $2.3 million," stated Robert Ehrlich, Chairman and CEO Arotech Corporation. "All parts of our business are performing well and ahead of our expectations. As a result, we are increasing our 2013 guidance, with expectations of full-year revenues growing to between $87 and $89 million and full-year EBITDA increasing to between $4.5 and $5.0 million," concluded Mr. Ehrlich.

First Six Months Results

Revenues for the first six months of 2013 reached $44.4 million, compared to $36.5 million for the corresponding period last year, an increase of 21.8%.

Gross profit for the first six months of 2013 was $11.6 million, or 26.1% of revenues, compared to $7.6 million, or 21.0% of revenues, for the corresponding period last year, a 5.1 point improvement in the gross margin percentage.

Adjusted Earnings (Loss) Before Interest, Taxes, Depreciation and Amortization (EBITDA) for the first six months of 2013 was $4.0 million, compared to $0.4 million for the corresponding period last year. Arotech believes that information concerning adjusted EBITDA enhances overall understanding of its current financial performance. Arotech computes adjusted EBITDA, which is a non-GAAP financial measure, as reflected in the table below.

The Company reported an operating profit for the first six months of 2013 of $2.4 million, compared to an operating loss of $(1.6) million for the corresponding period in 2012.

The Company's net income from continuing operations for the first six months of 2013 was $2.0 million, or $0.12 per diluted share, versus a net loss of $(2.4) million, or $(0.16) per share, for the corresponding period last year.

Backlog

Backlog of orders totaled approximately $65.7 million as of June 30, 2013, as compared to $87.3 million at June 30, 2012.

Cash Position at Quarter End

As of June 30, 2013, the Company had $1.0 million in cash and $0.5 million in restricted collateral deposits, as compared to December 31, 2012, when the Company had $1.6 million in cash and $0.2 million in restricted collateral deposits.

The Company also had $2.1 million in available, unused bank lines of credit with its main bank as of June 30, 2013, under a $15.0 million credit facility under its FAAC subsidiary, which was secured by the Company's assets and the assets of the Company's other subsidiaries and guaranteed by the Company.

The Company had trade receivables of $19.6 million as of June 30, 2013, compared to $9.6 million as of December 31, 2012. The Company had a current ratio (current assets/current liabilities) of 1.43 as of June 30, 2013 and 1.37 as of December 31, 2012.

Revised Guidance

For the full year 2013, Arotech's management anticipates that revenues will range from $87 million to $89 million. This is an increase from the former guidance range of between $85 million and $87 million.

Management also expects adjusted EBITDA for 2013 to be in the range of between $4.5 million and $5.0 million, a significant increase from the formerly expected range of between $2.9 million and $3.4 million.

The financial guidance provided is as of today and Arotech undertakes no obligation to update its estimates in the future. 

Conference Call

The Company will host a conference call tomorrow, Tuesday, August 13, 2013 at 9:30 a.m. EDT. Those wishing to access the conference call should dial 1-866-229-7198 (U.S.) or +1-347-293-1926 (international) a few minutes before the 9:30 a.m. EDT start time. For those unable to participate, the teleconference will be available for replay on Arotech's website at http://www.arotech.com/ beginning 24 hours after the call.

About Arotech Corporation

Arotech Corporation is a leading provider of quality defense and security products for the military, law enforcement and homeland security markets. Arotech provides multimedia interactive simulators/trainers and advanced zinc-air and lithium batteries and chargers. Arotech operates through two major business divisions: Training and Simulation, and Batteries and Power Systems.

Arotech is incorporated in Delaware, with corporate offices in Ann Arbor, Michigan and research, development and production subsidiaries in Alabama, Michigan and Israel.

Investor Relations Contacts:

Ehud Helft & Kenny Green

CCG Investor Relations

Tel: 1 646 201 9246

arotech@gkir.com


Except for the historical information herein, the matters discussed in this news release include forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, readers are cautioned not to place undue reliance on these forward-looking statements, as they are subject to various risks and uncertainties that may cause actual results to vary materially. These risks and uncertainties include, but are not limited to, risks relating to: product and technology development; the uncertainty of the market for Arotech's products; changing economic conditions; delay, cancellation or non-renewal, in whole or in part, of contracts or of purchase orders (including as a result of budgetary cuts resulting from automatic sequestration under the Budget Control Act of 2011); and other risk factors detailed in Arotech's most recent Annual Report on Form 10-K for the fiscal year ended December 31, 2012 and other filings with the Securities and Exchange Commission. Arotech assumes no obligation to update the information in this release. Reference to the Company's website above does not constitute incorporation of any of the information thereon into this press release.

TABLES TO FOLLOW

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(U.S. Dollars, except share data)






Six months ended June 30,


Three months ended June 30,


2013


2012


2013


2012

Revenues

$      44,449,973


$      36,480,838


$      22,396,842


$      20,373,130









Cost of revenues

32,865,162


28,832,494


16,088,195


17,013,427

Research and development expenses

1,128,170


1,046,961


594,785


455,808

Selling and marketing expenses

2,620,258


2,613,194


1,383,252


1,328,301

General and administrative expenses

4,854,058


5,001,385


2,466,247


2,000,779

Amortization of intangible assets

550,112


601,305


273,618


299,934

Total operating costs and expenses

42,017,760


38,095,339


20,806,097


21,098,249









Operating income (loss)

2,432,213


(1,614,501)


1,590,745


(725,119)









Other income

268,682


753


267,449


561

Financial expenses, net

(302,879)


(379,000)


(113,742)


(342,164)

Total other expense

(34,197)


(378,247)


153,707


(341,603)

Income (loss) from continuing operations before income
    tax expense

2,398,016


(1,992,748)


1,744,452


(1,066,722)









Income tax expense

428,902


397,154


254,125


199,577

Income (loss) from continuing operations

1,969,114


(2,389,902)


1,490,327


(1,266,299)

Loss from discontinued operations, net of income tax

(87,930)


(1,571,201)


(13,187)


(1,635,361)

Net income (loss)

1,881,184


(3,961,103)


1,477,140


(2,901,660)









Other comprehensive income, net of income tax








Foreign currency translation adjustment

269,923


(171,511)


58,247


(338,586)

Comprehensive income (loss)

$        2,151,107


$      (4,132,614)


$        1,535,387


$      (3,240,246)









Basic net income/loss per share – continuing operations

$               0.13


$            (0.16)


$             0.10


$            (0.09)

Basic net income/loss per share – discontinued operations

$              (0.01)


$            (0.11)


$             0.00


$            (0.11)

Basic net income/loss per share

$               0.12


$            (0.27)


$             0.10


$            (0.20)









Diluted net income/loss per share – continuing operations

$               0.12


$            (0.16)


$             0.09


$            (0.09)

Diluted net income/loss per share – discontinued operations

$             (0.01)


$            (0.11)


$             0.00


$            (0.11)

Diluted net income/loss per share

$              0.11


$            (0.27)


$             0.09


$            (0.20)

Weighted average number of shares used in computing
    basic net income/loss per share

15,472,667


14,691,577


15,554,199


14,728,352

Weighted average number of shares used in computing
    diluted net income/loss per share

16,075,407


14,691,577


16,146,939


14,728,352

 

Reconciliation of Non-GAAP Financial Measure – Continuing Operations

 

To supplement Arotech's consolidated financial statements presented in accordance with U.S. GAAP, Arotech uses a non-GAAP measure, Earnings (Loss) Before Interest, Taxes, Depreciation and Amortization (EBITDA). This non-GAAP measure is provided to enhance overall understanding of Arotech's current financial performance and its progress towards GAAP profitability. Reconciliation of EBITDA to the nearest GAAP measure follows:


Six months ended June 30,


Three months ended June 30,


2013


2012


2013


2012

Net Income (loss) continuing (GAAP measure)

$        1,969,114


$     (2,389,902)


$      1,490,327


$   (2,901,660)

Add back:








Financial (income) expense – including interest

302,879


379,000


113,742


342,164

Income tax expenses (benefit)

428,902


397,154


254,125


199,577

Depreciation and amortization expense

1,133,017


1,154,708


561,760


580,330

Other adjustments*

166,533


851,423


69,477


1,691,351

Total adjusted EBITDA

$        4,000,445


$         392,383


$      2,489,431


$        (88,238)

                                                                                 
*
Includes stock compensation expense, one-time transaction expenses, and other non-cash expenses.

SOURCE Arotech Corporation

Add a Comment

News   More...

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Content Partners
Morningstar - 2013/8/12 - Arotech Corporation Reports Record Results For The Second Quarter And First Six Months Of 2013
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Author |  Collection |  Interest |  Popularity

Previous: Arotech Corporation Reports Record Results For The Fourth Quarter And Full Year 2013  |  Next: Arotech Corporation Reports Record Results For The Third Quarter And First Nine Months, 2013